Treatment Indications: correction of moderate-depth wrinkles,, volume restoration in areas with moderate tissue atrophy (marionette lines, nasolabial folds),, facial soft tissue contouring
Release form: 1 × 1.0 mL pre‑filled sterile syringe
Compound: cross-linked hyaluronic acid of non-animal origin (produced by bacterial fermentation), cross-linking agent — BDDE
Concentration of GC: 20 mg/mL.
Lidocaine: 0.3 %.
Indications: intradermal and subdermal administration for correction of age-related facial skin changes, restoration of lost volume, skin surface smoothing, and improvement of dermal hydration.